165 related articles for article (PubMed ID: 15104192)
1. Safety of rush immunotherapy to multiple aeroallergens in an adult population.
Harvey SM; Laurie S; Hilton K; Khan DA
Ann Allergy Asthma Immunol; 2004 Apr; 92(4):414-9. PubMed ID: 15104192
[TBL] [Abstract][Full Text] [Related]
2. Premedication reduces the incidence of systemic reactions during inhalant rush immunotherapy with mixtures of allergenic extracts.
Portnoy J; Bagstad K; Kanarek H; Pacheco F; Hall B; Barnes C
Ann Allergy; 1994 Nov; 73(5):409-18. PubMed ID: 7978533
[TBL] [Abstract][Full Text] [Related]
3. Nonfatal systemic allergic reactions induced by skin testing and immunotherapy.
Lin MS; Tanner E; Lynn J; Friday GA
Ann Allergy; 1993 Dec; 71(6):557-62. PubMed ID: 8267250
[TBL] [Abstract][Full Text] [Related]
4. [Safety analysis of dust mite allergen for diagnosis and immunotherapy of asthma and rhinitis].
Wen T; Cai Y; Chen X; Xiang L; Wang B; Zhuang Y
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1999; 17(5):274-6. PubMed ID: 12563856
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of allergen immunotherapy in the treatment of allergic rhinitis and asthma in real life.
Zeldin Y; Weiler Z; Magen E; Tiosano L; Kidon MI
Isr Med Assoc J; 2008 Dec; 10(12):869-72. PubMed ID: 19160945
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for adverse systemic reactions occurring during immunotherapy with standardized Dermatophagoides farinae extracts.
Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Washio Y; Ohno Y; Yamada K; Nasako Y
Acta Otolaryngol Suppl; 1998; 538():113-7. PubMed ID: 9879410
[TBL] [Abstract][Full Text] [Related]
7. Systemic tolerability of specific subcutaneous immunotherapy with index-of-reactivity-standardized allergen extracts administered using clustered regimens: a retrospective, observational, multicenter study.
Serrano P; Justicia JL; Sánchez C; Cimarra M; Fernández-Távora L; Orovitg A; Moreno C; Guerra F; Alvà V
Ann Allergy Asthma Immunol; 2009 Mar; 102(3):247-52. PubMed ID: 19354072
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy with mosquito (Culex quinquefasciatus) extract: a double-blind, placebo-controlled study.
Srivastava D; Singh BP; Sudha VT; Arora N; Gaur SN
Ann Allergy Asthma Immunol; 2007 Sep; 99(3):273-80. PubMed ID: 17910332
[TBL] [Abstract][Full Text] [Related]
9. Allergen immunotherapy-induced biphasic systemic reactions: incidence, characteristics, and outcome: a prospective study.
Confino-Cohen R; Goldberg A
Ann Allergy Asthma Immunol; 2010 Jan; 104(1):73-8. PubMed ID: 20143649
[TBL] [Abstract][Full Text] [Related]
10. Analysis of safety, risk factors and pretreatment methods during rush hymenoptera venom immunotherapy.
Gorska L; Chelminska M; Kuziemski K; Skrzypski M; Niedoszytko M; Damps-Konstanska I; Szymanowska A; Siemińska A; Wajda B; Drozdowska A; Jutel M; Jassem E
Int Arch Allergy Immunol; 2008; 147(3):241-5. PubMed ID: 18594155
[TBL] [Abstract][Full Text] [Related]
11. Systemic reactions with aeroallergen cluster immunotherapy in a clinical practice.
Copenhaver CC; Parker A; Patch S
Ann Allergy Asthma Immunol; 2011 Nov; 107(5):441-7. PubMed ID: 22018617
[TBL] [Abstract][Full Text] [Related]
12. Advances in upper airway diseases and allergen immunotherapy.
Nelson HS
J Allergy Clin Immunol; 2007 Apr; 119(4):872-80. PubMed ID: 17292953
[TBL] [Abstract][Full Text] [Related]
13. Incidence and characteristics of biphasic reactions after allergen immunotherapy.
Scranton SE; Gonzalez EG; Waibel KH
J Allergy Clin Immunol; 2009 Feb; 123(2):493-8. PubMed ID: 19064282
[TBL] [Abstract][Full Text] [Related]
14. Accelerated immunotherapy schedules: review of efficacy and safety.
Cox L
Ann Allergy Asthma Immunol; 2006 Aug; 97(2):126-37; quiz 137-40, 202. PubMed ID: 16937741
[TBL] [Abstract][Full Text] [Related]
15. [Safety of immunotherapy and skin tests with allergens in children younger than five years].
Rodríguez Pérez N; Ambriz Moreno Mde J
Rev Alerg Mex; 2006; 53(2):47-51. PubMed ID: 16884027
[TBL] [Abstract][Full Text] [Related]
16. Safety of immunotherapy with therapeutic vaccines containing depigmented and polymerized allergen extracts.
Casanovas M; Martín R; Jiménez C; Caballero R; Fernández-Caldas E
Clin Exp Allergy; 2007 Mar; 37(3):434-40. PubMed ID: 17359393
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of high-doses sublingual immunotherapy in ultra-rush scheme in children allergic to grass pollen.
Stelmach I; Kaczmarek-Woźniak J; Majak P; Olszowiec-Chlebna M; Jerzynska J
Clin Exp Allergy; 2009 Mar; 39(3):401-8. PubMed ID: 19134016
[TBL] [Abstract][Full Text] [Related]
18. [Preventive immunotherapy].
Boquete M; Carballada F; Expósito F; González A
Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
[TBL] [Abstract][Full Text] [Related]
19. The determinants of bronchial hyperresponsiveness in patients with allergic rhinitis.
Mete N; Sin A; Gulbahar O; Erdinc M; Sebik F; Kokuludag A
Ann Allergy Asthma Immunol; 2004 Aug; 93(2):193-9. PubMed ID: 15328682
[TBL] [Abstract][Full Text] [Related]
20. Side-effects of allergen-specific immunotherapy: a prospective multi-centre study.
Winther L; Arnved J; Malling HJ; Nolte H; Mosbech H
Clin Exp Allergy; 2006 Mar; 36(3):254-60. PubMed ID: 16499635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
